Vertex Pharmaceuticals (VRTX) Gains from Investment Securities (2009 - 2025)
Vertex Pharmaceuticals (VRTX) reported Gains from Investment Securities of -$2.6 million for Q3 2025, compared with -$10.8 million a year earlier.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Gains from Investment Securities (2009 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Vertex Pharmaceuticals' Gains from Investment Securities came in at $41.3 million; for FY2024, it was $3 million.
- Gains from Investment Securities has a five-year compound annual growth rate of -56.7% (FY2019 to FY2024).
- By year, Gains from Investment Securities came in at -$600,000 in FY2023, -$149.1 million in FY2022, $17.1 million in FY2021 (-94.5%) and $311.9 million in FY2020 (+57.8%).
- Five-year quarterly Gains from Investment Securities spans a low of -$84.2 million in Q2 2022 and a high of $171.03 million in Q4 2020.
- Per Business Quant data, the three quarters before Q3 2025 came in at -$12.6 million (Q2 2025), $3 million (Q1 2025) and $53.5 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | -12.60 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 53.50 Mn |
| Sep 30, 2024 | -10.80 Mn |
| Jun 30, 2024 | -12.70 Mn |
| Mar 31, 2024 | -27.00 Mn |
| Dec 31, 2023 | -400,000.00 |
| Sep 30, 2023 | -6.20 Mn |
| Jun 30, 2023 | -400,000.00 |
| Mar 31, 2023 | 6.40 Mn |
| Dec 31, 2022 | -6.00 Mn |
| Sep 30, 2022 | 16.70 Mn |
| Jun 30, 2022 | -84.20 Mn |
| Mar 31, 2022 | -75.60 Mn |
| Dec 31, 2021 | 12.10 Mn |
| Sep 30, 2021 | 46.70 Mn |
| Jun 30, 2021 | 10.60 Mn |
| Mar 31, 2021 | -52.30 Mn |
| Dec 31, 2020 | 171.03 Mn |
API Access
Vertex Pharmaceuticals Gains from Investment Securities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-investment-securities", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();